Prevalence and estimated incidence of blood-borne viral pathogen infection in organ and tissue donors from northern Alberta

American Journal of Transplantation

Volumn 7, Issue 1, 2007, Pages 226-234

  Zahariadis, G ^a,c   Plitt, S S ^b,c   O'Brien, S ^d,e   Yi, Q L ^d   Fan, W ^d   Preiksaitis, J K ^a,c  

^a PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d CANADIAN BLOOD SERVICES   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Nucleic acid testing; Tissue organ donor; Transmission; Virus

Indexed keywords

NUCLEIC ACID;

ADULT; AGED; ARTICLE; CANADA; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN TISSUE; INFECTION RISK; MALE; NUCLEIC ACID ANALYSIS; ORGAN DONOR; PRIORITY JOURNAL; RISK ASSESSMENT; SEROPREVALENCE; TIME SERIES ANALYSIS; VIRUS INFECTION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

EID: 33845682512     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01607.x     Document Type: Article

References (16)

1. Zou S, Dodd R, Stramer S, Strong D. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med 2004; 351(8): 751-759.
2. Stramer SL, Glynn SA, Kleinman SH Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004; 351(8): 760-768.
3. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996; 334(26): 1685-1690.
4. American Association of Tissue Banks. AATB Bulletin. In. Sept 9, 2004.
5. O'Brien SF, Fan W, Scalia V, Goldman M, Fearon MA, Vamvakas EC. Detection of hepatitis C virus and human immunodeficiency virus-1 antibody-negative donations: Canadian Blood Services' experience with nucleic acid testing. Vox Sang 2006; 90(3): 204.
6. Jarvis LM, Dow BC, Cleland A et al. Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing. Vox Sang 2005; 89(3): 128-134.
7. Korelitz JJ, Busch MP, Kleinman SH et al. A method for estimating hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study. Transfusion 1997; 37(6): 634-640.
8. Dodd RY, Notari EP, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002; 42(8): 975-979.
9. Janssen RS, Satten GA, Stramer SL et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998; 280(1): 42-48.
10. Kleinman S, Busch MP, Korelitz JJ, Schreiber GB. The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection. Transfus Med Rev 1997; 11(3): 155-172.
11. Lackritz EM, Satten GA, Aberle-Grasse J et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 1995; 333(26): 1721-1725.
12. Chiavetta JA, Escobar M, Newman et al. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. CMAJ 2003; 169(8): 767-773.
13. Alberta Immunization Manual. Edmonton: Alberta Health and Wellness; January, 2001.
14. Challine D, Pellegrin B, Bouvier-Alias M, Rigot P, Laperche L, Pawlotsky JM. HIV and hepatitis C virus RNA in seronegative organ and tissue donors. Lancet 2004; 364(9445): 1611-1612.
15. Aswad S, Khan NS, Comanor L et al. Role of nucleic acid testing in cadaver organ donor screening: Detection of hepatitis C virus RNA in seropositive and seronegative donors. J Viral Hepat 2005; 12(6): 627-634.
16. Tugwell BD, Patel PR, Williams IT et al. Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Ann Intern Med 2005; 143(9): 648-654.